Assessing Weight Gain upon Discontinuation of Tirzepatide Treatment
The SURMOUNT-4 randomized clinical trial evaluates the efficacy of continuous tirzepatide treatment for maintaining weight loss in adults with obesity, providing valuable insights for long-term management.
August 2024